Jukka Laine

Jukka Laine

Auto-generated profile, based on publicly available information

Jukka Laine

Genomill Health Inc., Turku, Finland; Department of Pathology, University of Turku, Turku, Finland; TYKS Laboratories, Department of Pathology, Turku University Hospital, Turku, Finland

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2017 in Diabetes Care
Verified
Journal Article
Open access
PDF file
HIHeidi Immonen
Heidi Immonen
JHJarna C. Hannukainen
Jarna C. Hannukainen
NKNobuyuki Kudomi
Nobuyuki Kudomi
JPJussi Pihlajamäki
Jussi Pihlajamäki
VSVirva Saunavaara
Virva Saunavaara
PNPirjo Nuutila
Pirjo Nuutila
OBJECTIVE: Changes in liver fatty acid metabolism are important in understanding the mechanisms of diabetes remission and metabolic changes after bariatric surgery. RESEARCH DESIGN AND METHODS: Liver fatty acid uptake (LFU), blood flow, and fat content (LFC) were measured in 25 obese subjects before bariatric surgery and 6 months after using positron emission tomography/computed tomography and MRS; 14 lean individuals served as the control subjects. RESULTS: The increased LFU in obese subjects was associated with body adiposity. LFU was reduced postoperatively but was still high compared with the control subjects. LFC was normalized. Liver blood flow (per unit volume) was higher in obese subjects than in the control subjects at baseline and was further increased postoperatively; however, the total organ blood flow was unchanged as the liver volume decreased. CONCLUSIONS: The findings suggest that in a postoperative state, intrahepatic fatty acids are not stored in the liver but are used for oxidation to provide energy. Changes in perfusion may contribute to improved liver metabolism postoperatively.

5 July 2024 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
MVMadhukar Vedantham
Madhukar Vedantham
LPLauri Polari
Lauri Polari
APAnbu Poosakkannu
Anbu Poosakkannu
RPRita G. Pinto
Rita G. Pinto
MSMoona Sakari
Moona Sakari
Arto PulliainenArto Pulliainen
Arto Pulliainen
Inflammatory bowel disease (IBD) is a chronic disease of the gastrointestinal tract affecting millions of people. Here, we investigated the expression and functions of poly(ADP‐ribose) polymerase 14 (Parp14), an important regulatory protein in immune cells, with an IBD patient cohort as well as two mouse colitis models, that is, IBD‐mimicking oral dextran sulfate sodium (DSS) exposure and oral Salmonella infection. Parp14 was expressed in the human colon by cells in the lamina propria, but, in particular, by the epithelial cells with a granular staining pattern in the cytosol. The same expression pattern was evidenced in both mouse models. Parp14‐deficiency caused increased rectal bleeding as well as stronger epithelial erosion, Goblet cell loss, and immune cell infiltration in DSS‐exposed mice. The absence of Parp14 did not affect the mouse colon bacterial microbiota. Also, the colon leukocyte populations of Parp14‐deficient mice were normal. In contrast, bulk tissue RNA‐Seq demonstrated that the colon transcriptomes of Parp14‐deficient mice were dominated by abnormalities in inflammation and infection responses both prior and after the DSS exposure. Overall, the data indicate that Parp14 has an important role in the maintenance of colon epithelial barrier integrity. The prognostic and predictive biomarker potential of Parp14 in IBD merits further investigation.

1 July 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AGAparna Ganesan
Aparna Ganesan
AKAnttoni Korkiakoski
Anttoni Korkiakoski
SASimona Adamusová
Simona Adamusová
AMAnna Musku
Anna Musku
TRTuula Rantasalo
Tuula Rantasalo
ARAri Ristimäki
Ari Ristimäki
Colorectal cancer (CRC) is the second leading cause of cancer-related deaths, often presenting at an advanced stage with significant molecular heterogeneity. This is the first study to evaluate the performance of a novel next-generation sequencing (NGS)-based Bridge Capture technology for mutation profiling and minimal residual disease detection in circulating tumor (ct)DNA from metastatic colorectal cancer (mCRC) patients. Its performance was compared to those of droplet digital PCR (ddPCR), Ion AmpliSeq Cancer Hotspot Panel v2, and Idylla ctKRAS Mutation Assay. Eighty serial plasma samples from ten mCRC patients were analyzed by Bridge Capture and ddPCR, demonstrating a very strong correlation in variant allele frequency (VAF) values (rs = 0.86). The concordance of Bridge Capture with ddPCR (kappa = 0.70) and Idylla (kappa = 0.79) showed substantial agreement. A subset of samples (n = 10) was analyzed using the Ion AmpliSeq NGS-panel and both methods identified 15 driver mutations with strong correlation of VAF values (rs = 0.74). Additionally, Bridge Capture identified several oncogenic mutations beyond those detected by Ion AmpliSeq, highlighting its comprehensive profiling capability. The scalability of Bridge Capture was validated using an expanded panel and synthetic DNA targets, showing a strong linear correlation between observed and expected VAF values. This study demonstrates the scalability and accuracy of the Bridge Capture platform, and its potential to enhance mutation detection and clinical decision-making using ctDNA samples from patients with mCRC.

9 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
SASimona Adamusova
Simona Adamusova
NLNea Laine
Nea Laine
AKAnttoni Korkiakoski
Anttoni Korkiakoski
THTatu Hirvonen
Tatu Hirvonen
AMAnna Musku
Anna Musku
JPJuha-Pekka Pursiheimo
Juha-Pekka Pursiheimo
Circular single-stranded DNA (CssDNA) offers unique advantages for molecular diagnostics and next-generation sequencing (NGS) due to its nuclease resistance and compatibility with rolling circle amplification. We present the Nicking Loop™, a novel and versatile method for converting both single- and double-stranded DNA into CssDNA and enabling robust, unbiased amplification. This technique preserves the original DNA template composition and outperforms PCR in reproducibility and sensitivity, particularly for low variant allele frequencies. We demonstrate that Nicking Loop-amplified CssDNA is directly compatible with NGS platforms utilizing circular DNA as a sequencing template and introduce a novel loop-based indexing strategy that enables efficient sample multiplexing. Furthermore, we confirm the method's compatibility with Nanopore sequencing technologies, highlighting its broad applicability across sequencing platforms. Our results establish Nicking Loop™ as an alternative to conventional linear library preparation, streamlining workflows while enhancing sequencing accuracy and efficiency. Beyond its immediate application in NGS, the method holds promise for broader use in molecular biology, e.g. in DNA data storage. This proof-of-concept study highlights the transformative potential of Nicking Loop™ in enabling a shift toward circular DNA libraries for new generation of assay preps and precision sequencing applications.

16 October 2025 in Pediatric and Developmental Pathology
Verified
Journal Article
Open access
NTNea Tulonen
Nea Tulonen
JTJussi Tallus
Jussi Tallus
HKHeidi Kaprio
Heidi Kaprio
JLJukka Laine
Jukka Laine
MMMirjami Mattila
Mirjami Mattila
SKSini Keskinen
Sini Keskinen
Congenital diaphragmatic hernia is a genetically heterogeneous condition with a developmental defect in the diaphragm. The GATA4 gene is essential for fetal heart development, and pathogenic GATA4 variants are a known cause of structural congenital heart diseases. Haploinsufficiency of GATA4 is also associated with diaphragmatic hernia. Pathogenic GATA4 sequence variants with isolated diaphragmatic hernia in the absence of congenital heart defects are extremely rare. Our report expands the phenotypic spectrum related to GATA4 . We report a fetus with a prenatal isolated diaphragmatic hernia detected during a routine screening ultrasound. An autopsy of the fetus confirmed a large isolated posterolateral hernia, which affected the left lung volume significantly. Clinical exome sequencing revealed a novel heterozygous nonsense variant c.826C>T,p.(Gln276*) in the GATA4 gene, which was predicted to cause haploinsufficiency. The variant occurred de novo and was classified as pathogenic. The report presents a detailed clinical description of the fetus with ultrasound, MRI, and post-mortem pictures of a rare prenatal isolated diaphragmatic hernia related to a novel pathogenic GATA4 sequence variant. Prenatal ultrasound screening with further investigation by MRI and a comprehensive gene panel holds a key role in determining the prognosis of a fetus with a diaphragmatic hernia.

18 October 2025 in The Journal of Molecular Diagnostics
Verified
Journal Article
Open access
SASimona Adamusová
Simona Adamusová
AKAnttoni Korkiakoski
Anttoni Korkiakoski
NLNea Laine
Nea Laine
AMAnna Musku
Anna Musku
TRTuula Rantasalo
Tuula Rantasalo
MTManu Tamminen
Manu Tamminen
Liquid biopsies quantifying mutations in circulating tumor DNA by targeted next-generation sequencing have been gaining popularity. They are performed by various library preparation methods, each with distinct advantages and limitations. This work introduces Bridge Capture, a novel technology that goes beyond the advantages of market-leading liquid biopsy technologies, eliminating the need to compromise between scalability, cost-efficiency, sensitivity, or panel size. Twenty-four matched contrived colorectal biospecimens mimicking circulating tumor DNA were analyzed by Bridge Capture, Archer LIQUIDPlex, and AmpliSeq CHP version 2 for Illumina to compare variant allele frequency (VAF) detection. Bridge Capture was evaluated for sequencing depth requirement, interlaboratory reproducibility, automatization, and panel scalability. Of all methods, Bridge Capture detected the lowest VAF, and all VAFs strongly correlated with Archer LIQUIDPlex (R2 = 0.995) and AmpliSeq CHPv2 for Illumina (R2 = 0.988). Owing to its unique design, the Bridge Capture is compatible with the commonly used next-generation sequencing platforms and effectively uses sequencing capacity, permitting affordable and sensitive variant detection. The method demonstrated high reproducibility across independent laboratories and between automated and manual workflow. The panel size was increased by 300% and had negligible impact on performance and cross-reactivity of the probes, implying high multiplexing capabilities. Taken together, Bridge Capture is a cost-efficient, simple, rapid, and sensitive cancer diagnostics tool that has a potential to significantly improve the detection of mutations.